Stephen Hall has joined Helicos BioSciences as senior vice president and chief financial officer. He replaces Louise Mawhinney, who resigned from Helicos in March. Prior to joining Helicos, Hall was a managing director and founder of Deimos Consulting, a management consulting firm. Before that, he was senior vice president and chief financial officer of TriPath Imaging, and later senior advisor at Becton Dickinson, which acquired TriPath in late 2006. Hall holds an MBA from Stanford University’s Graduate School of Business and a AB from Harvard College.
Cold Spring Harbor Laboratory President Bruce Stillman has been elected to the American Academy of Arts and Sciences. He will be inducted at a ceremony on Oct. 11 at the academy’s headquarters in Cambridge, Mass. Stillman, a native of Australia, holds a PhD from the John Curtin School of Medical Research at the Australian National University and a BSc from the University of Sydney. His research focuses on DNA replication.
David Norwood, Riccardo Pigliucci, Trevor Nicholls, and Hagan Bayley have been appointed to the board of nanopore sequencing company Oxford Nanolabs, In Sequence has learned. Bayley is a company founder and a professor of chemistry at the University of Oxford. Norwood, who chairs the board, is director of special projects at IP Group, one of the company’s investors. Pigliucci is a former president and chief operating officer of Perkin Elmer. Nicholls is a former chief commercial officer of Affymetrix and the former commercial director of the life-science business of Amersham International, now part of GE Healthcare.
Harry Glorikian has joined the board of directors of GeneNews, a company developing blood-based biomarker tests for the early detection of diseases and personalized health management. Glorikian is a managing partner of Scientia Advisors, a management and strategy consulting firm. Prior to that, he held various positions at Applied Biosystems, including senior manager for new technology assessment and business development.